Susceptibility of Enterobacteriaceae to β-lactam agents and fluoroquinolones: A 3-year survey in France

Clinical Microbiology and Infection

Volumn 8, Issue 4, 2002, Pages 207-213

  Sirot, J ^a,q   Nicolas Chanoine, M H ^b   Chardon, H ^c   Avril, J L ^d   Cattoen, C ^e   Croix, J C ^f   Dabernat, H ^g   Fosse, T ^h   Ghnassia, J C ⁱ   Lecaillon, E ^j   Marmonier, A ^k   Roussel Delvallez, M ^l   Soussy, C J ^m   Trevoux, A ⁿ   Vandenesch, F ^o   Dib, C ^p   Moniot Ville, N ^p   Rezvani, Y ^p  

^a Centre Hospitalo Universitaire   (France)

^b APHPAmbroise Paré Hospital   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e CENTRE HOSPITALIER DE VALENCIENNES   (France)

^f CENTRE HOSPITALIER DE TROYES   (France)

^g CHU PURPAN   (France)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ CENTRE HOSPITALIER DE VERSAILLES   (France)

^j Centre Hospitalier de Perpignan   (France)

^k Centre Hospitalier du Mans   (France)

^l LILLE UNIVERSITY HOSPITAL   (France)

^m HENRI MONDOR HOSPITAL   (France)

ⁿ Hôpitaux Universitaires de Strasbourg   (France)

^o Centre Hospitalo Universitaire Louis Pradel   (France)

^p SANOFI   (France)

^q UNIVERSITÉ CLERMONT AUVERGNE   (France)

more..

Author keywords

Enterobacteriaceae; Fluoroquinolones; Resistance; lactams

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; IMIPENEM; LATAMOXEF; NALIDIXIC ACID; OFLOXACIN; PEFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLONING; CONTROLLED STUDY; DIFFUSION; DRUG POTENTIATION; DRUG SCREENING; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; FRANCE; HOSPITAL LABORATORY; KLEBSIELLA PNEUMONIAE; MULTICENTER STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

EID: 0036526238     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00393.x     Document Type: Article

References (25)

1. Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: A 3-year survey in France
2. Vigil'Roc Study Group. Characterization of ceftriaxone-resistant Enterobacteriaceae: A multicenter study in 26 French hospitals
3. Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France
4. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents
5. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones
6. The growing problem of nosocomial bacterial resistance. An epidemiological perspective with emphasis on the fluoroquinolones
7. The Sentry Participants Group. Geographical distribution of quinolone resistance among Staphylococcus aureus, Escherichia coli and Klebsiella spp. Isolates from 20 European university hospitals
8. Report of the Comité de I'Antibiogramme de la Société Française de Microbiologie
9. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns
10. Detection of extended-spectrum plasmid-mediated β-lactamases by disk diffusion
11. Controlling the false discovery rate: A practical and powerful approach to multiple testing
12. Recommandations méthodologiques du Coǹseil scientifique de I'ONERBA pour la surveillance de la résistance aux antibiotiques
13. Sensibilité comparée du céfotétan vis-à-vis de 17652 souches d'entérobactéries (CHRU de Lille, 1993-1995)
14. Evolution de la sensibilité des bacilles à Gram négatif à la ceftazidime et à trois autres bêta-lactamines en milieu hospitalier de à 1993
15. Etude de la sensibilité à I'Augmentin® de 998 souches de Escherichia coli isolées en 1992 dans quatre centres hospitaliers français (Etude COLICERIB I)
16. Etude des souches de E. coli résistants à I'augmentin à l'hôpital Laennec à Nantes
17. Résistance d'Escherichia coli à I'amoxicilline-acide clavulanique au CHU de Nimes, France: Etude prospective du 15 novembre 98 au 15 février 99
18. Antibiotic resistance in Escherichia coli isolated from blood and cerebrospinal fluid: A 6-year study of isolates from patients in England and Wales
19. Antibiotic resistance patterns among blood culture isolates in a Danish country 1981-1995
20. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital
21. Epidemiological typing of Klebsiellae with extended-spectrum beta-lactamases from European intensive care units
22. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998
23. Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe
24. Most Enterobacter aerogenes strains in France belong to a prevalent clone